DMII · Drugs Made In America Acquisition II Corp.

Substantial doubt about the company's ability to continue as a going concern.

“In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”

View the 10-Q filed May 14, 2026